P8IP
Pier 88 Investment Partners Portfolio holdings
AUM
$538M
1-Year Return
9.78%
This Quarter Return
-2.06%
1 Year Return
+9.78%
3 Year Return
+26.16%
5 Year Return
+53.5%
10 Year Return
–
AUM
$521M
AUM Growth
+$13.1M
(+2.6%)
Cap. Flow
-$299M
Cap. Flow
% of AUM
-57.41%
Top 10 Holdings %
Top 10 Hldgs %
44.91%
Holding
112
New
14
Increased
34
Reduced
29
Closed
7
Top Buys
| 1 |
NEE.PRT
NextEra Energy, Inc. 7.234% Corporate Units
NEE.PRT
|
+$16.5M |
| 2 |
ARES.PRB
Ares Management Corporation 6.75% Series B Mandatory Convertible Preferred Stock
ARES.PRB
|
+$6.67M |
| 3 |
Penumbra
PEN
|
+$4.14M |
| 4 |
Okta
OKTA
|
+$3.49M |
| 5 |
Tradeweb Markets
TW
|
+$3.38M |
Top Sells
Sector Composition
| 1 | Technology | 6.72% |
| 2 | Healthcare | 3.05% |
| 3 | Consumer Discretionary | 2.51% |
| 4 | Industrials | 1.5% |
| 5 | Financials | 1.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FPI
51
Farmland Partners
FPI
$481M
| $706K | 0.14% |
63,340
-1,190
| -2% | -$13.3K |
|
52
Revolve Group
RVLV
$1.59B
| $704K | 0.14% |
32,780
+16,740
| +104% | +$360K |
|
53
ITT
ITT
$13.8B
| $692K | 0.13% |
5,360
-21,380
| -80% | -$2.76M |
|
54
Confluent
CFLT
$6.63B
| $682K | 0.13% |
+29,090
| New | +$682K |
|
55
Freshworks
FRSH
$3.63B
| $675K | 0.13% |
+47,850
| New | +$675K |
|
56
Coherent
COHR
$16B
| $638K | 0.12% |
9,820
+4,280
| +77% | +$278K |
|
57
ATI
ATI
$10.5B
| $634K | 0.12% |
12,182
+4,562
| +60% | +$237K |
|
58
PROS Holdings
PRO
$699M
| $630K | 0.12% |
33,100
-45,790
| -58% | -$871K |
|
59
Arista Networks
ANET
$175B
| $617K | 0.12% |
7,960
+120
| +2% | +$9.3K |
|
60
Denali Therapeutics
DNLI
$2.07B
| $611K | 0.12% |
44,910
-500
| -1% | -$6.8K |
|
61
HubSpot
HUBS
$25.9B
| $588K | 0.11% |
1,030
-1,290
| -56% | -$737K |
|
62
Chart Industries
GTLS
$8.95B
| $559K | 0.11% |
3,870
-1,920
| -33% | -$277K |
|
63
AbCellera Biologics
ABCL
$1.34B
| $544K | 0.1% |
243,790
+6,890
| +3% | +$15.4K |
|
64
Datadog
DDOG
$47.6B
| $519K | 0.1% |
5,230
-3,670
| -41% | -$364K |
|
65
Halozyme
HALO
$8.99B
| $507K | 0.1% |
+7,950
| New | +$507K |
|
66
Recursion Pharmaceuticals
RXRX
$2.11B
| $501K | 0.1% |
94,790
-66,940
| -41% | -$354K |
|
67
Astera Labs
ALAB
$38.1B
| $493K | 0.09% |
+8,260
| New | +$493K |
|
68
Procept Biorobotics
PRCT
$2.07B
| $433K | 0.08% |
7,430
-2,000
| -21% | -$117K |
|
69
Iovance Biotherapeutics
IOVA
$821M
| $423K | 0.08% |
126,940
+72,310
| +132% | +$241K |
|
70
DTE Energy
DTE
$28.4B
| $400K | 0.08% |
2,894
| – | – |
|
71
Pyxis Oncology
PYXS
$113M
| $383K | 0.07% |
390,960
+292,370
| +297% | +$286K |
|
72
Rocket Pharmaceuticals
RCKT
$341M
| $379K | 0.07% |
56,820
+19,320
| +52% | +$129K |
|
73
Keysight
KEYS
$29.3B
| $377K | 0.07% |
2,515
-400
| -14% | -$59.9K |
|
74
Dominion Energy
D
$51.2B
| $242K | 0.05% |
4,315
| – | – |
|
75
DexCom
DXCM
$29.9B
| $223K | 0.04% |
3,260
-3,140
| -49% | -$214K |
|